Genetic Testing Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2017

2012-01-17
Published : Jan-2012

Report Summary

GlobalData’s new report, “Genetic Testing Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2017” provides key market data on the Genetic Testing market in the BRICS countries. The report provides value ($m) data for each segment and sub-segment within three market categories – Inborn Gene or Chromosome Alterations, Other Genetic Tests and Acquired Gene or Chromosome Alterations. The report also provides company shares and distribution shares data for the overall Genetic Testing market in each of the aforementioned countries. The report is also supplemented with global corporate-level profiles of the key market participants with information on key developments, wherever available.

This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData’s team of industry experts.

The emerging economies, comprising China, India, Brazil, Russia and South Africa, with a significantly large pool of under-served patients, represent the next big opportunity for the leading medical equipment and devices manufacturers. China remains the world’s most populous country and is consequently home to a large patient base. The country is home to more than 120 million people who are aged 65 or older—a population in continuous need of medical care. India, the second most populous country globally, is home to 1.2 billion people, approximately 5% of which are aged 65 or older. It’s estimated that shortly after 2020, India’s population will surpass China, making it the most populous country in the world. As the population continues to grow and people continue to age, the underlying demand for healthcare is also expected to increase.

Reasons to buy

  • Develop business strategies by identifying the key market categories and segments poised for strong growth.
  • Develop market-entry and market expansion strategies.
  • Design competition strategies by identifying who-stands-where in the Genetic Testing competitive landscape in BRICS.
  • Develop capital investment strategies by identifying the key market segments expected to register strong growth in the near future.
  • What are the key distribution channels and what’s the most preferred mode of product distribution – Identify, understand and capitalize.

BRICS  Genetic Testing Market

Published: January 2012
No.OF Pages: 112
Price: Single User License – US$ 2500      Corporate User License US$ 7500

Table of Contents

1 Table of Contents 2
1.1 List of Tables 6
1.2 List of Figures 8

2 Introduction 10
2.1 What is This Report About? 10

3 Genetic Testing in BRICS 11
3.1 Genetic Testing, BRICS, Overall Revenue ($m), 2003-2017 11
3.2 Genetic Testing, BRICS, Company share (2009-2010) 17

4 Genetic Testing In Brazil 19
4.1 Genetic Testing, Brazil, Overall Revenue ($m), USD Actual, 2003-2017 19
4.2 Inborn Gene or Chromosome Alterations In Brazil 25
4.2.1 Inborn Gene or Chromosome Alterations, Brazil, Overall Revenue (2003-2017) 25
4.3 Other Genetic Tests In Brazil 27
4.3.1 Other Genetic Tests, Brazil, Overall Revenue (2003-2017) 27
4.4 Acquired Gene or Chromosome Alterations In Brazil 29
4.4.1 Acquired Gene or Chromosome Alterations, Brazil, Overall Revenue (2003-2017) 29
4.5 Genetic Testing, Brazil, Distribution Share (2009-2010) 31
4.6 Genetic Testing, Brazil, Company Share (2009-2010) 32

5 Genetic Testing In Russian Federation 34
5.1 Genetic Testing, Russian Federation, Overall Revenue ($m), USD Actual, 2003-2017 34
5.2 Inborn Gene or Chromosome Alterations in Russian Federation 40
5.2.1 Inborn Gene or Chromosome Alterations, Russian Federation, Overall Revenue (2003-2017) 40
5.3 Other Genetic Tests In Russian Federation 42
5.3.1 Other Genetic Tests, Russian Federation, Overall Revenue (2003-2017) 42
5.4 Acquired Gene or Chromosome Alterations In Russian Federation 44
5.4.1 Acquired Gene or Chromosome Alterations, Russian Federation, Overall Revenue (2003-2017) 44
5.5 Genetic Testing, Russian Federation, Distribution Share (2009-2010) 47
5.6 Genetic Testing, Russian Federation, Company Share (2009-2010) 48

6 Genetic Testing In India 50
6.1 Genetic Testing, India, Overall Revenue ($m), USD Actual, 2003-2017 50
6.2 Inborn Gene or Chromosome Alterations in India 56
6.2.1 Inborn Gene or Chromosome Alterations, India, Overall Revenue (2003-2017) 56
6.3 Other Genetic Tests In India 58
6.3.1 Other Genetic Tests, India, Overall Revenue (2003-2017) 58
6.4 Acquired Gene or Chromosome Alterations In India 60
6.4.1 Acquired Gene or Chromosome Alterations, India, Overall Revenue (2003-2017) 60
6.5 Genetic Testing, India, Distribution Share (2009-2010) 62
6.6 Genetic Testing, India, Company Share (2009-2010) 63

7 Genetic Testing In China 65
7.1 Genetic Testing, China, Overall Revenue ($m), USD Actual, 2003-2017 65
7.2 Inborn Gene or Chromosome Alterations In China 71
7.2.1 Inborn Gene or Chromosome Alterations, China, Overall Revenue (2003-2017) 71
7.3 Other Genetic Tests In China 73
7.3.1 Other Genetic Tests, China, Overall Revenue (2003-2017) 73
7.4 Acquired Gene or Chromosome Alterations In China 75
7.4.1 Acquired Gene or Chromosome Alterations, China, Overall Revenue (2003-2017) 75
7.5 Genetic Testing, China, Distribution Share (2009-2010) 77
7.6 Genetic Testing, China, Company Share (2009-2010) 78

8 Genetic Testing In South Africa 80
8.1 Genetic Testing, South Africa, Overall Revenue ($m), USD Actual, 2003-2017 80
8.2 Inborn Gene or Chromosome Alterations In South Africa 86
8.2.1 Inborn Gene or Chromosome Alterations, South Africa, Overall Revenue (2003-2017) 86
8.3 Other Genetic Tests In South Africa 88
8.3.1 Other Genetic Tests, South Africa, Overall Revenue (2003-2017) 88
8.4 Acquired Gene or Chromosome Alterations In South Africa 90
8.4.1 Acquired Gene or Chromosome Alterations, South Africa, Overall Revenue (2003-2017) 90
8.5 Genetic Testing, South Africa, Distribution Share (2009-2010) 92
8.6 Genetic Testing, South Africa, Company Share (2009-2010) 93

9 Overview of Key Companies in BRICS Genetic Testing Market 95
9.1 F. Hoffmann-La Roche Ltd. 95
9.1.1 Company Overview 95
9.1.2 Share in the BRICS Genetic Testing Market 96
9.2 Abbott Laboratories 97
9.2.1 Company Overview 97
9.2.2 Share in the BRICS Genetic Testing Market 98
9.3 Siemens Healthcare 99
9.3.1 Company Overview 99
9.3.2 Share in the BRICS Genetic Testing Market 100
9.4 Qiagen N.V. 101
9.4.1 Company Overview 101
9.4.2 Share in the BRICS Genetic Testing Market 102
9.5 Bio-Rad Laboratories, Inc. 103
9.5.1 Company Overview 103
9.5.2 Share in the BRICS Genetic Testing Market 104
9.6 Gen-Probe Incorporated 105
9.6.1 Company Overview 105
9.6.2 Share in the BRICS Genetic Testing Market 106

10 Appendix 107
10.1 Definitions of Markets Covered in the Report 108
10.1.1 Genetic Testing 108
10.2 Research Methodology 109
10.3 Secondary Research 109
10.4 Primary Research 110
10.5 Models 110
10.6 Forecasts 111
10.7 Expert Panels 111
10.8 GlobalData Consulting 111
10.9 Currency Conversion 112
10.10 Contact Us 112
10.11 Disclaimer 112

List of Tables & Figures

Filed in: Medical Device
Tags: 
More Reports
Title Price Buy Now

Wound Care Market by Product (Dressings (Foam, Film, Hydrocolloid, Collagen), Devices (NPWT, Assessment, Debridement), Graft, Matrix, Suture, Stapler), Wound(DFUs, Trauma, Surgical, Burn), End User (Hospitals, Clinics) & Region – Global Forecast to 2027

“Increased cases of traumatic injuries and increasing surgical procedures worldwide are driving the overall growth of the wound care market” The global wound care market is projected to reach USD 27.2 billion by 2027 from USD 20.8 billion in 2022, at a CAGR of 5.4% during the forecast period. Market growth is driven by factors such as increase in traumatic injuries, increased in number of surgical wounds and increased spending on traumatic wound management. On the other hand, challenges associated with wound care product validation and shortage of skilled professionals are the major factors hampering the growth of this market. “The advanced wound care products segment accounted for the highest growth rate in the wound care market, by product, during the forecast period” T......
 $8150

Rehabilitation Equipment Market by Product (Medical Bed, Mobility Scooter, Walker, Crutcher, Cane, Patient Lift, Sling), Application (Physical, OT, Lower-body Exercise Equipment), End User (Rehabilitation & Physiotherapy Center) – Global Forecast to 2027

“The rehabilitation equipment market is projected to grow at a CAGR of 5.9% between 2022 and 2027.” The global rehabilitation equipment market is projected to reach USD 19.8 billion by 2027 from USD 14.9 billion in 2022, at a CAGR of 5.9% during the forecast period. Increasing geriatric population and obese populations, increasing chronic diseases, high risk of injuries to caregivers during the manual handling of patients, and increasing demand for rehabilitation care, owing to an increasing access to healthcare are the key driving factors in the market. However, a lack of awareness and access to rehabilitation services in emerging countries is a major factor restraining market growth. “Therapy equipment was the largest and fastest-growing segment in the product segment of reha......
 $4950

Cold Pain Therapy Market by Product (OTC (Gels, Creams, Patches, Wraps, Pads), Prescription (Motorized, Non-motorized)), Application (Musculoskeletal, Post-Op, Sports Injuries), Distribution Channel (Hospital, Retail, E-Pharmacy) – Global Forecast to 2027

"Increasing sports injuries and active participation are driving the overall growth of the cold pain therapy market." The global cold pain therapy market is projected to reach USD 2.4 billion by 2027 from USD 1.8 billion in 2022, at a CAGR of 5.1% during the forecast period. Growth in this market is mainly driven by growing incidence of arthritis and availability of cold pain products at affordable cost. "The OTC products segment accounted for the highest growth rate in the cold pain therapy market, by product, during the forecast period." The cold pain therapy market is segmented into OTC products and prescription products based on product. In 2021, the OTC products segment accounted for the highest growth rate in the cold pain therapy market. Market growth can largely be attri......
 $4950

Nerve Repair & Regeneration Market by Products (Neuromodulation Devices (Deep Brain Stimulation, Vagus Nerve Stimulation), Biomaterials (Nerve Conduits, Nerve Wraps), Application (Neurorrhaphy, Nerve Grafting, Stem Cell Therapy) – Global Forecast to 2027

“Increasing research investments into the neurological compilations and the expanding geriatric population are pushing the growth of the nerve repair & regeneration market.” The global nerve repair & regeneration market is expected to reach USD 11.6 billion by 2027 from USD 6.5 billion in 2022, at a CAGR of 12.1%.The growth in this market is driven by increasing research expenditure on the neurological disorders by the government, the increasing R&D investments by the market players into the neuromodulation and neurostimulation devices and the biomaterials. Also, the expanding geriatric population base dries the growth of the market by placing more demand of the nerve repair and regeneration products. “The biomaterialas segment is anticipated to grow at the fastest ......
 $4950

Particle Therapy Market by Type (Proton Therapy, Heavy Ion), Products (Cyclotron, Synchrotron, Synchrocyclotron), Services, System (Single-room, Multi-room), Cancer Type (Pediatric, Prostate), Application (Treatment, Research) – Global Forecast to 2027

MarketsandMarkets expects particle therapy market is projected to reach USD 1,004 million by 2027 from USD 677 million in 2022, growing at a CAGR of 8.2% from 2022 to 2027. Market growth is driven by factors such as the various advantages offered by the growing global prevalence of cancer, particle therapy advantages over photon therapy, increasing acceptance of particle therapy in clinical trials, and the increasing number of particle therapy centers worldwide. However, affordability & accessibility of treatments and infrastructural are expected to limit market growth to a certain extent in the coming years. In this report, the particle therapy market is segmented on the basis of type, product and services, cancer type, application, cancer type, and region. “Treatment Applicat......
 $4950

Restorative Dentistry Market by Product (Restorative Material (Glass-ionomers, Bonding Agents, Biomaterial), Implant, Prosthetic, Equipment (Handpiece, Articulator, Furnace), End User (Hospital, Clinic, Laboratory) – Global Forecast to 2027

“The global restorative dentistry market is projected to grow at a CAGR of 6.1%” Restorative dentistry restores mouth functions & its aesthetic state by efficiently managing oral health problems through dental restoration. Dental restoration procedures include the use of implants and prosthetics made by restorative material to restore the function, integrity, and morphology of the missing tooth or to repair the missing parts of the tooth structure resulted from dental caries or injuries. The global restorative dentistry market is projected to reach USD 22.2 billion by 2027 from USD 16.5 billion in 2022, at a CAGR of 6.1%. “The prosthetic materials segment is expected to account for the largest share of the restorative dentistry market” The prosthetic materials segment ......
 $4950

Dental Laboratories Market by Material (Metal Ceramic, CAD/CAM Material (Zirconia, Glass Ceramic)), Equipment (Milling Equipment, CAD/CAM System, 3D Printing System, Scanner, Furnace), Prosthetics (Bridge, Crown, Veeners, Denture) – Global Forecast to 2027

“Rapid growth in the geriatric population and the associated increase in the prevalence of edentulism is expected to drive the overall growth of the dental laboratories market.” Edentulism (tooth loss) is a major oral health concern among the elderly; according to the WHO (2020), globally, ~19% of individuals aged between 65 and 74 years are edentulous. Periodontal diseases and dental cavities are the major causes of tooth loss. As the elderly are more susceptible to such ailments, the growth of this population segment will increase the number of people suffering from oral health problems globally. According to the UN, the global geriatric population (aged 65 years and above) will increase from 703 million in 2019 to 1.5 billion in 2050. Thus, significant growth in the geriatric pop......
 $4950

Endoscope Reprocessing Market by Product (HLD and Test Strips, Detergents & Wipes, Automated Endoscope Reprocessors (AER), Endoscope Drying, Storage, & Transport Systems, Tracking Solutions), End User (Hospitals, ASCs & Clinics) (2022 – 2027)

“Endoscope reprocessing market is projected to grow at CAGR of 9.7% from 2022 to 2027” The global endoscope reprocessing market is projected to USD 3.8 billion by 2027 from USD 2.4 billion in 2022, at a CAGR of 9.7% from 2022 to 2027.The growth of this market is driven owing to increasing requirement for endoscopy to diagnose and treat target diseases, high risk of Endoscope-associated infections due to contaminated endoscopes, Growing geriatric population and leading to increase in endoscopic procedures, and Increasing emphasis on improving reprocessing guidelines by healthcare authorities. Also, Increasing investments, funds, and grants to improve healthcare infrastructure and research areas of endoscopy is anticipated to offer an opportunity for the growth of the market during th......
 $4950

Polymethyl Methacrylate (PMMA) Market by Grade (General Purpose, Optical), Form(Extruded Sheet, Cast Acrylic Sheet, Pellets, Beads),End-Use Industry(Signs & Displays, Construction, Automotive, Lighting Fixtures, Electronics, Marine, Healthcare) & Region – Global Forecast to 2027

“Rising demand from the electronics industry and expected recovery from impact of COVID-19 and rising penetration of EVs expected to drive market.” The global Polymethyl Methacrylate (PMMA) market is projected to grow from USD 4.8 Billion in 2022 to USD 6.3 Billion by 2027, at a CAGR of 5.4% during the forecast period. Increasing usage of PMMA in construction, automotive, electronics, and other end-use industries are driving the demand for PMMA during the forecast period. However, availability of low-cost substitutes is expected to hamper market growth. PMMA is a versatile, recyclable, sustainable, and durable material, owing to which it is gaining traction across several industrial applications. Due to its superior properties and the changing government policies such as European Gr......
 $4950

Microtome Market by Product (Instruments, (Rotary), Accessories (Microtome Blades), Application (Disease Diagnosis, Medical Research), Technology (Fully Automated, Semi-automated, Manual), End User (Hospital, Clinical Labs) – Global Forecast to 2027

“The hospital laboratories is projected to grow at CAGR of 7.1% from 2022 to 2027” Based on End user the market is classified into, The hospital laboratories, clinical laboratories, and other end users . The growth of this market is majorly driven by the increasing number of specialty diagnostic tests performed in hospital laboratories, rising number of in-house clinical diagnostic procedures in hospitals, rising number of hospitals across the globe, and the growing trend of establishing in-house clinical diagnostic capabilities in hospitals. “Microtome instruments in the product segment to witness the highest shares during the forecast period.” Based on the product, the microtome market is segmented into Microtome Instruments: Rotary Microtomes, Cryostat Microtomes, Vibra......
 $4950
We use cookies to deliver the best possible experience on our website.
By continuing to use this site, or closing this box, you consent to our use of cookies. To learn more, visit our Privacy Policy